Smoldering Myeloma was a hot topic at the recent American Society of Hematology meeting, Researchers are especially intent on discussing how to treat high risk Smoldering Myeloma - or patients who are most likely to progress to active myeloma within a 24 month period. A multitude of approaches are being used from single drugs to [...]
This post first appeared on Page Not Found - The Myeloma Crowd, please read the originial post: here